Cross-sectional study quantifies elevated seroprevalence in humans and livestock, suggesting intervention targets.
Rift Valley fever (RVF) transmission has intensified in southwestern Uganda since 2016. To quantify human and livestock exposure and associated risks, we conducted a cross-sectional serosurvey in Isingiro, Kabale and Rubanda districts between October and November 2023. A total of 766 humans and 2383 livestock were sampled and tested for RVF antibodies using ELISA, with structured questionnaires capturing demographic, behavioral and environmental data. Human seroprevalence was 11.5% (88/766), varying by district (13.8% Isingiro, 11.8% Rubanda, 6.8% Kabale; p = 0.04). Independent predictors from the multivariate model included raw-meat consumption (aOR 6.11; 95% CI 1.16–27.80), cattle ownership (aOR 2.33; 95% CI 1.27–4.36), male sex (aOR 1.64; 95% CI 1.02–2.66) and younger age compared with ≥50 years (31–49 years: aOR 2.02; 95% CI 1.20–3.48; 18–30 years: aOR 2.37; 95% CI 1.04–5.14). Herd-level seroprevalence was 42.5% (204/480), associated with cattle presence (aOR 6.48; 95% CI 4.10–10.40), lack of carcass burial (aOR 15.70; 95% CI 4.23–63.60), on-farm slaughter (aOR 2.14; 95% CI 1.21–3.89) and increased mosquito activity (aOR 1.75; 95% CI 1.13–2.73). Animal-level seroprevalence was 14.6% (347/2383), highest in cattle (33.8%), with cattle having markedly higher odds than goats (aOR 6.73; 95% CI 4.96–9.14). These findings demonstrate substantial transmission and highlight cattle-centered interfaces as primary targets for control to humans.
No takes yet. Share an insight, caveat, or question.
Nyakarahuka et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: